Ironwood Pharmaceuticals, Inc.

Ticker IRWD

Exchange NASDAQ More
Industry Drugs - Generic More
Sector Healthcare More

201-500 Employees
Based in Cambridge, Massachusetts

Ironwood Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, and commercialization of human therapeutic products. The company markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adult men and women suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZESS name in…More

Social Media Links

REPORT RATINGS

4.8 / 5.0 (281)

Ironwood Pharmaceuticals, Inc. reports have an aggregate usefulness score of 4.8 based on 281 reviews.

Ironwood Pharmaceuticals, Inc.

Most Recent Annual Report

MOST RECENT 2023 Annual Report and Form 10K

View PDF View Form 10K (HTML)

Ironwood Pharmaceuticals, Inc. does not currently have any hardcopy reports on 博九娱乐网. Click the button below to request a report when hardcopies become available.

Please fill out the form below and click "Place Order" to complete your order.